Back
Sonnet BioTherapeutics Holdings Vs. Simulations Plus Industry Stock Comparison
Buy
59
SONN
Sonnet BioTherapeutics Holdings
Last Price:
5.19
Seasonality Move:
-15.97%
Sell
30
SLP
Simulations Plus
Last Price:
30.22
Seasonality Move:
5.81%
Buy
59
Sonnet BioTherapeutics Holdings (SONN)
is a Buy
Is Sonnet BioTherapeutics Holdings a Buy, Sell or Hold?
- The current Sonnet BioTherapeutics Holdings [SONN] share price is $5.15. The Score for SONN is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- SONN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Simulations Plus (SLP)
is a Sell
Is Simulations Plus a Buy, Sell or Hold?
- The current Simulations Plus [SLP] share price is $30.22. The Score for SLP is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- SLP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SONN Stock Price Chart
What is Sonnet BioTherapeutics Holdings's stock price today?
-
The Sonnet BioTherapeutics Holdings share price today is $5.15
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SONN is experiencing slight buying pressure.
SLP Stock Price Chart
What is Simulations Plus's stock price today?
-
The Simulations Plus share price today is $30.22
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SLP is experiencing selling pressure, which indicates risk of future bearish movement.
SONN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.18 | Buy |
Relative Strength Index (14 RSI): | 37.57 | Sell |
Chaikin Money Flow: | 3391 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (-0.16 - 3.88) | Buy |
Bollinger Bands (100): | (0.18 - 2.42) | Buy |
SLP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.31 | Sell |
Relative Strength Index (14 RSI): | 30.89 | Sell |
Chaikin Money Flow: | -69284 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30.76 - 33.9) | Sell |
Bollinger Bands (100): | (33.91 - 46.71) | Sell |
SONN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.94 | Buy |
20-day SMA: | 2.12 | Buy |
50-day SMA: | 1.31 | Buy |
200-day SMA: | 1.51 | Buy |
8-day EMA: | 4.29 | Buy |
20-day EMA: | 2.79 | Buy |
50-day EMA: | 1.78 | Buy |
200-day EMA: | 2.95 | Buy |
SLP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.96 | Sell |
20-day SMA: | 31.69 | Sell |
50-day SMA: | 34.89 | Sell |
200-day SMA: | 41.59 | Sell |
8-day EMA: | 30.92 | Sell |
20-day EMA: | 31.96 | Sell |
50-day EMA: | 34.8 | Sell |
200-day EMA: | 40.17 | Sell |
Sonnet BioTherapeutics Holdings Earnings Growth & SONN Earnings Dates
- Analysts estimate an earnings increase this quarter of $5.61 per share, a decrease next quarter of $0.00 per share, an increase this year of $244.56 per share, and an increase next year of $11.01 per share.
Simulations Plus Earnings Growth & SLP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.09 per share, and an increase next year of $0.08 per share.
Sonnet BioTherapeutics Holdings Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Simulations Plus Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |